NHS-Galleri trial results show mixed outcomes for multi-cancer blood test
The NHS-Galleri trial, involving 142,250 participants, found that a multi-cancer early detection blood test did not significantly reduce late-stage cancer diagnoses overall, though it detected about 30% of cancers and had a high specificity.